Bolt Threads Still Commercializing

The key point is that Bolt is still selling projects, not yet selling a repeatable materials engine. Revenue moved from about $346K in 2022 to $3.4M in 2023, down to $1.4M in 2024, then up to $4.5M in 2025, which looks more like a small set of shipment decisions by brand partners than a steady base of contracted production or licensing fees. Its commercial center has also shifted from Mylo and Microsilk in fashion toward Vegan Silk in beauty, another sign the company is still searching for a durable wedge.1 3 4

• Bolt makes money today by selling bio based ingredients and materials into partner launches and trials. That means revenue lands when a customer places an order, restocks, or pauses, not as recurring software like income. A single concentrated customer cutting purchases drove the 2024 drop, and renewed shipments drove the 2025 rebound.1
• A predictable materials platform would usually show one of two patterns, either stable repeat orders from scaled production, or royalty like revenue from licensing into many downstream products. Bolt shows neither yet. The business remains small versus the capital put in, with about $4.5M of 2025 revenue against roughly $471M of prior funding and continued liquidity stress.1 3
• The product mix explains some of the lumpiness. Mylo built attention through a 2020 consortium with adidas, Kering, lululemon, and Stella McCartney, but it is no longer the main focus. Bolt is now pushing Vegan Silk into beauty and personal care, where commercialization depends on winning individual brand formulas and launches one by one.1 3 5

From here, the path to becoming a real platform is less about proving the science and more about proving repeat demand. If Bolt can turn Vegan Silk into routine ingredient volume across multiple beauty brands, revenue should start to look smoother and less customer specific. That would mark the transition from headline partnerships to an operating materials business.1 3